Shire posts strong revenue growth, shrugs off Vyvanse fears - Pharma Times (subscription)
|
Shire posts strong revenue growth, shrugs off Vyvanse fears
Pharma Times (subscription), UK - Apr 28, 2008 The drug is vital to the firm’s fortunes seeing as Adderall XR will face generic competition in 2009. Chief executive Matthew Emmens played down any fears … |
Find Out More:
Books:
April 30th, 2008
Adderall
Leave a Reply